Events & Presentations
Upcoming Webcasts
-
uniQure Third Quarter 2026 Earnings Update
8:30 a.m. - 9:30 a.m.
View Webcast
Webcast Archive
-
Phase I/II AMT-130 Huntington's Disease Update
8:30 a.m. - 9:30 a.m.
View Webcast -
uniQure Second Quarter 2026 Earnings Call
8:30 a.m. - 9:30 a.m. ET
View Webcast -
Pivotal Phase I/II AMT-130 Huntington's Disease Update
8:30 a.m. ET - 9:30 a.m. ET
View Webcast -
Regulatory Update on AMT-130 for Huntington's Disease
8:30 a.m. ET - 9:30 a.m. ET
View Webcast
Investor Presentations
-
Phase I/II AMT-130 Additional Data Update – Phase I/II AMT-130 Update 36 Month Data and 48 Month Analysis - September 2026
View Presentation -
Pivotal Phase I/II AMT-130 Program Update – Phase I/II AMT-130 Pivotal 36 Month Analysis - September 2025
View Presentation -
CHDI - 2026 HD Therapeutics Conference – AMT-130: Propensity Score Adjustment Mitigates Potential Bias from Striatal Volume Absence in Enroll-HD
View Presentation -
9th Epilepsy Pipeline Conference – GenTLE Phase I/IIa Clinical Study of AMT-260: Preliminary Results of an Investigational Gene Therapy for Refractory MTLE
View Presentation -
2026 WORLDSympsium – AMT-191 investigational gene therapy in adult males with classic Fabry disease; preliminary safety and biomarker data of Phase I/IIa study
View Presentation -
Gene Therapy Information
View Presentation